Keywords: Sanofi-Aventis, Genzyme, Hostile offer direct to shareholders

Sanofi-Aventis goes hostile with $69/share offer for Genzyme

Article | 04 October 2010

Print This

In what now looks set to be a protracted battle to gain control of troubled US biotechnology firm Genzyme (Nasdaq: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in